| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.23 | 6e-07 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.22 | 6e-06 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.22 | 0.0001 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.16 | 0.0002 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.17 | 0.0007 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.089 | 0.07 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.072 | 0.1 |